Organ On Chip revenue was USD 88 Million in 2022 and is forecast to a readjusted size of USD 621.2 Million by 2029 with a CAGR of 31.2% - Valuates Reports

Organ On Chip revenue was USD 88 Million in 2022 and is forecast to a readjusted size of USD 621.2 Million by 2029 with a CAGR of 31.2% during the review period (2023-2029). Key drivers of the organ-on-chip market include growing research and development initiatives for replacing animal testing models in drug testing and clinical trials.

Get sample report - https://reports.valuates.com/request/sample/QYRE-Auto-26C1860/Global_Organ_On_Chip_Market_Research_Report_2020

Trends Influencing the Global Organ On Chip Market
Cell cultures and animal models are used throughout the drug discovery and development process. Chemical compounds are tested on cells not found in human bodies. This causes clinical trials to fail and the approval process to be delayed. As a result, governments, pharmaceutical companies, and researchers are increasing funding for the development of alternatives such as organ-on-chip technology. The chips are byte-sized computer memory that contains human cells that have been dipped into blood vessels and tissues to mimic the function of a living organ. This has the potential to completely replace traditional lab testing methods. Thus, the gradual expansion of research will create enormous opportunities for the future growth of the organ-on-chip market.

The growing prevalence of cardiovascular diseases has increased the demand for organs on chips. The chips are capable of accurately simulating the human cardiovascular system, including physiological shear stress conditions, mechanical stretching, and electronic stimulation. Heart and vessel-based chips are valuable assets for approaching personalized cardiovascular medications and improving patient care. During the forecast period, the organ-on-chip market will be driven by ongoing research, drug application, and efficacy testing.

Organ-on-chip technology has the potential to evaluate human-specific data on drug efficacy and toxicity very early in the development process. This opens up a wide range of possibilities for easier and faster detection. Furthermore, technology is evolving at a rapid pace as market participants seek out newer models. Human cells can be grown on the chips in micro-controlled environments. On a single chip, multiple organs can be simulated, providing detailed information about the inner workings of the human body. These factors are expected to propel the organ-on-chip market forward in the coming years.

By Type
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Brain-on-a-chip
Vessel-on-a-chip

By Application
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Cosmetics Industry
Other End Users

Get detailed report - https://reports.valuates.com/market-reports/QYRE-Auto-26C1860/global-organ-on-chip

Similar report -

https://reports.valuates.com/market-reports/QYRE-Auto-1G6255/global-lung-on-a-chip

https://reports.valuates.com/reports/INFO-Othe-4E50/biopreservation

https://reports.valuates.com/market-reports/QYRE-Auto-37P5886/global-kidney-on-a-chip

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at sales@valuates.com

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.